EMAIL DETAILS

That’s great, Derrick. Thanks so much. Glad to hear things are proceeding with Buba. John is a great guy and very smart about this stuff.

Look forward to hearing how everything goes on May 20th.

Best,

Eric


Eric D. Schwerin
Rosemont Seneca Partners, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>
P Consider the environment before printing this email.

> On May 11, 2016, at 10:31 AM, Derrick Johns <derrick@difusiontech.com> wrote:
>
>
> Eric,
>
> Attached please find the executed and notarized Warrant grant for the help you provided with China. As you will see we have increased the previously agreed upon grant by 3x as a token of my appreciation for the recent referral you provided. When you speak with John and hear his solution strategy for Buba Jobakar you will understand the increased grant.
>
> I am in DC on May 20th for an FDA meeting, provided that meeting goes as planned we will begin our exit process via Capstone Partners in Boston. Capstone has assigned a beginning enterprise valuation of $7.70 per share and we expect to significantly exceed that number in an managed auction process.
>
> Again, thank you for the recent introduction. He definitely has a sound strategy for Buba’s return home.
>
> Derrick W. Johns
> CEO and Founder
> <1D44E4A7-AEC9-4D1E-A8ED-AAE1A3C8FDAD.png>
> www.difusiontech.com
>
> “The Leader in Medical Polymers”
>
> (512) 863-7777 o
> (512) 284-3338 c
>
>
> <Skaneateles Grant.pdf><1D44E4A7-AEC9-4D1E-A8ED-AAE1A3C8FDAD.png>